We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.05B
AUM Growth
-$342M
Cap. Flow
-$333M
Cap. Flow %
-8.21%
Top 10 Hldgs %
11.89%
Holding
2,058
New
529
Increased
346
Reduced
400
Closed
620

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 11.64%
3 Consumer Discretionary 10.2%
4 Industrials 7.56%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELVN icon
401
Enliven Therapeutics
ELVN
$4.23B
$2.36M 0.06%
104,890
-27,943
-21% -$724K
BLDR icon
402
Builders FirstSource
BLDR
$8.06B
$2.35M 0.06%
16,437
-17,695
-52% -$3.13M
ENS icon
403
EnerSys
ENS
$7.08B
$2.34M 0.06%
25,358
-2,172
-8% -$211K
HOOD icon
404
Robinhood
HOOD
$83.6B
$2.34M 0.06%
+62,904
New +$2.03M
MDB icon
405
MongoDB
MDB
$30.1B
$2.34M 0.06%
10,066
+7,842
+353% +$2.21M
INSM icon
406
Insmed
INSM
$21.5B
$2.33M 0.06%
33,805
-9,912
-23% -$714K
EVLVW
407
DELISTED
Evolv Technologies Warrant
EVLVW
$2.33M 0.06%
590,079
+114,998
+24% +$32.2K
KMX icon
408
CarMax
KMX
$8.29B
$2.32M 0.06%
28,325
+24,860
+717% +$1.95M
TOWN icon
409
Towne Bank
TOWN
$3.52B
$2.31M 0.06%
67,850
-87,506
-56% -$3.04M
FCF icon
410
First Commonwealth Financial
FCF
$2.22B
$2.31M 0.06%
+136,433
New +$2.41M
GMED icon
411
Globus Medical
GMED
$11B
$2.31M 0.06%
27,896
-142,371
-84% -$11.2M
RARE icon
412
Ultragenyx Pharmaceutical
RARE
$2.53B
$2.29M 0.06%
54,455
-11
-0% -$546
IMVT icon
413
CALL
Immunovant
IMVT
$8.11B
$2.27M 0.06%
91,800
-58,400
-39% -$1.66M
FROG icon
414
JFrog
FROG
$10.2B
$2.27M 0.06%
77,142
+4,056
+6% +$123K
MOD icon
415
Modine Manufacturing
MOD
$10.9B
$2.26M 0.06%
19,524
+3,765
+24% +$484K
GPCR icon
416
Structure Therapeutics
GPCR
$3.52B
$2.25M 0.06%
83,148
+49,485
+147% +$1.76M
MTSI icon
417
MACOM Technology Solutions
MTSI
$20.8B
$2.25M 0.06%
17,309
-933
-5% -$117K
HCP
418
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$2.25M 0.06%
65,625
FUN icon
419
Cedar Fair
FUN
$1.83B
$2.24M 0.06%
46,516
-97,375
-68% -$4.27M
RSI icon
420
Rush Street Interactive
RSI
$2.9B
$2.24M 0.06%
163,278
-112,667
-41% -$1.37M
OPRA
421
Opera Ltd
OPRA
$1.8B
$2.24M 0.06%
118,205
-4,947
-4% -$88.2K
CALM icon
422
PUT
Cal-Maine
CALM
$3.98B
$2.22M 0.05%
+21,600
New +$2.04M
EHC icon
423
Encompass Health
EHC
$11B
$2.2M 0.05%
23,869
-49,090
-67% -$4.82M
WBD icon
424
Warner Bros
WBD
$65.6B
$2.2M 0.05%
+208,119
New +$1.93M
GAMB
425
DELISTED
Gambling.com
GAMB
$2.18M 0.05%
155,162
+38,394
+33% +$452K

Similar funds

Boothbay Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, Boothbay Fund Management held 2,058 positions worth $4.05B, down 7.8% from $4.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boothbay Fund Management withdrew a net $333M in Q4 2024, closing 620 positions and reducing 400 holdings. Its most notable exit was Nova Vision Acquisition Corp. Warrant, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Cardinal Health worth $10.8M.

  • Boothbay Fund Management's largest Q4 2024 buy was Cardinal Health: 91,430 shares worth $10.8M.
  • Boothbay Fund Management added most to Arthur J. Gallagher & Co in Q4 2024, an estimated $20M increase.
  • Boothbay Fund Management's biggest Q4 2024 reduction was Dell, cutting an estimated $36.8M.
  • Boothbay Fund Management fully exited Nova Vision Acquisition Corp. Warrant in Q4 2024, selling an estimated $18.1M.
  • Boothbay Fund Management's ten largest holdings make up 12% of its $4.05B portfolio in Q4 2024.
  • Boothbay Fund Management opened 529 new positions and closed 620 in Q4 2024.
  • Boothbay Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.05B.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.